$740 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 10 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | $106,783,000 | -23.9% | 5,744,096 | 0.0% | 14.43% | -44.2% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $45,685,000 | +43.9% | 4,938,893 | 0.0% | 6.17% | +5.5% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $44,482,000 | -14.5% | 2,965,485 | 0.0% | 6.01% | -37.3% | |
| CELG | CELGENE CORP | $10,339,000 | -2.0% | 111,844 | 0.0% | 1.40% | -28.1% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $4,441,000 | -67.2% | 349,400 | 0.0% | 0.60% | -76.0% | |
| PRTA | PROTHENA CORP PLC | $3,423,000 | -12.9% | 323,823 | 0.0% | 0.46% | -36.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.